Expect more with Siegfried as your preferred partner

Bringing together our long-standing pharma and chemical heritage, we offer as an integrated partner benefit to our customers with more synergy, expertise and value. 

Explore more about how our broad range of custom development services, drug substance & drug product manufacturing capabilities, together with our existing product portfolio may help you achieve greater value. 

May 13, 2015

(SIX: SFZN) RAG-Stiftung Beteiligungsgesellschaft mbH based in Essen, Germany, will participate in a hybrid bond of Siegfried ... Read more »

May 07, 2015

Siegfried acquires significant segments of BASF’s pharmaceutical supply business  Read more »

SitemapRSS FeedsDisclaimer